Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Long-Term Deferred Tax: 2009-2025

Historic Long-Term Deferred Tax for Gyre Therapeutics (GYRE) over the last 2 years, with Sep 2025 value amounting to $6.7 million.

  • Gyre Therapeutics' Long-Term Deferred Tax rose 30.09% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 30.09%. This contributed to the annual value of $5.6 million for FY2024, which is 19.68% up from last year.
  • Latest data reveals that Gyre Therapeutics reported Long-Term Deferred Tax of $6.7 million as of Q3 2025, which was up 9.46% from $6.1 million recorded in Q2 2025.
  • Gyre Therapeutics' 5-year Long-Term Deferred Tax high stood at $6.7 million for Q3 2025, and its period low was $4.1 million during Q4 2022.
  • For the 3-year period, Gyre Therapeutics' Long-Term Deferred Tax averaged around $5.5 million, with its median value being $5.4 million (2024).
  • Data for Gyre Therapeutics' Long-Term Deferred Tax shows a peak YoY surged of 30.09% (in 2025) over the last 5 years.
  • Gyre Therapeutics' Long-Term Deferred Tax (Quarterly) stood at $4.1 million in 2022, then grew by 15.05% to $4.7 million in 2023, then increased by 19.68% to $5.6 million in 2024, then surged by 30.09% to $6.7 million in 2025.
  • Its Long-Term Deferred Tax stands at $6.7 million for Q3 2025, versus $6.1 million for Q2 2025 and $5.8 million for Q1 2025.